Compare ZLAB & HOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZLAB | HOG |
|---|---|---|
| Founded | 2013 | 1903 |
| Country | China | United States |
| Employees | N/A | 6400 |
| Industry | Biotechnology: Pharmaceutical Preparations | Motor Vehicles |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.9B |
| IPO Year | 2017 | 1994 |
| Metric | ZLAB | HOG |
|---|---|---|
| Price | $22.62 | $26.93 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 15 |
| Target Price | ★ $33.14 | $27.90 |
| AVG Volume (30 Days) | 712.3K | ★ 1.9M |
| Earning Date | 11-05-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 2.73% |
| EPS Growth | ★ 38.46 | N/A |
| EPS | N/A | ★ 0.97 |
| Revenue | $460,156,000.00 | ★ $4,473,175,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $26.50 | $3.80 |
| P/E Ratio | ★ N/A | $28.32 |
| Revenue Growth | ★ 15.33 | N/A |
| 52 Week Low | $15.96 | $17.09 |
| 52 Week High | $30.00 | $28.86 |
| Indicator | ZLAB | HOG |
|---|---|---|
| Relative Strength Index (RSI) | 34.34 | 54.06 |
| Support Level | $16.97 | $26.22 |
| Resistance Level | $27.14 | $28.76 |
| Average True Range (ATR) | 1.03 | 0.83 |
| MACD | -0.36 | 0.24 |
| Stochastic Oscillator | 9.48 | 79.73 |
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.
Harley-Davidson is a leading global manufacturer of heavyweight motorcycles across the custom, cruising, and touring categories, as well as related merchandise, parts, and accessories. In recent years, the firm has expanded into the adventure touring market with its Pan America model, into electric with the LiveWire brand, and is returning to smaller-displacement bikes with the Sprint. Its captive finance arm, Harley-Davidson Financial Services, provides wholesale financing to dealers and retail financing and insurance brokerage services to customers. Harley captured around 34% of the heavyweight domestic market in 2025.